BIBF0775 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific kinases involved in cell proliferation and survival pathways. This compound is often employed in preclinical studies to evaluate its efficacy in suppressing tumor growth and metastasis. Researchers use it to understand the mechanisms of kinase inhibition and its potential therapeutic benefits in various cancer types. Additionally, BIBF0775 is instrumental in developing combination therapies, where it is tested alongside other anticancer agents to enhance treatment outcomes. Its role in advancing targeted cancer treatments makes it a valuable tool in oncology research.